Changeflow GovPing Healthcare Fluorogenic Styrene Probes for Visualizing RNA ...
Routine Notice Added Final

Fluorogenic Styrene Probes for Visualizing RNA in Live Cells

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Diagnosis & Surgery (A61B)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has published patent application EP2024196850A1 concerning the development of highly fluorogenic styrene probes for visualizing RNA in live cells. This publication details a new technological advancement in cellular imaging, potentially impacting research and development in the life sciences.

What changed

The European Patent Office (EPO) has published patent application EP2024196850A1, detailing novel fluorogenic styrene probes designed for visualizing RNA within live cells. This application, published on March 18, 2026, outlines specific chemical compositions and methods for their use in advanced cellular imaging techniques. The publication does not currently list any designated inventors, indicating that the inventor designation process may still be ongoing.

This patent publication represents a new development in biotechnology and diagnostic tools. While it does not impose immediate compliance obligations, it signals potential future advancements in research and diagnostic capabilities. Companies involved in life sciences research, diagnostics, and pharmaceutical development should monitor this patent application as it progresses through the examination process, as it could lead to new intellectual property and commercial opportunities or challenges in the field of cellular imaging and RNA detection.

Source document (simplified)

← EPO Patent Bulletin

DEVELOPMENT OF HIGHLY FLUOROGENIC STYRENE PROBES FOR VISUALIZING RNA IN LIVE CELLS

Publication EP2024196850A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

A61B 5/00 20060101AFI20240927BHEP C07D 209/04 20060101ALI20240927BHEP C07D 213/04 20060101ALI20240927BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2024196850A1

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
RNA Visualization Cellular Imaging
Geographic scope
European Union EU

Taxonomy

Primary area
Healthcare
Operational domain
Research and Development
Topics
Biotechnology Research and Development

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Diagnosis & Surgery (A61B) publishes new changes.

Free. Unsubscribe anytime.